Tanzeel Alamin Almahdi Gorashi: NLR as an Accessible Biomarker for Monitoring Pediatric Sickle Cell Anemia
Tanzeel Alamin Almahdi Gorashi, Former Medical Laboratory Technologist at Alshareef Lab, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Global Journal of Medical and Clinical Case Reports, adding:
”Proud to share our recently published study on the Neutrophil-to-Lymphocyte Ratio (NLR) in pediatric sickle cell anemia in Gezira State, Sudan.
The findings highlight NLR as an accessible, low-cost biomarker of inflammation and its potential role in monitoring disease activity and response to hydroxyurea therapy.”
Title: Neutrophil-to-Lymphocyte Ratio in Pediatric Sickle Cell Anemia: A Case-Control Study from Gezira State, Sudan
Authors: Sara Nasreldeen Abdelrahman Mohammed, Tanzeel Alamin Almahdi Gorashi, Khalid Abdelsamea Mohamedahmed
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 3, 2026, 16:35Mohsen Salimi: Non-Contrast Chest CT as a Biomarker for Mild-to-Moderate Anemia
-
Sep 3, 2026, 15:42Manuel De Jesus: Innovating Anemia Monitoring Through Biomedical Engineering and Digital Technology
-
Sep 3, 2026, 15:37Hadis Nabipoor: QICL2026 Highlights the Critical Importance of Transfusion Safety
-
Sep 3, 2026, 15:32Gopal Patidar: The ISBT Haemovigilance Working Party Sharing Knowledge and Promoting Best Practices
-
Sep 3, 2026, 15:24Bhalchandra Kawdikar: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 15:18Massimo Martino: Redefining Allogeneic Transplantation in Myelofibrosis
-
Sep 3, 2026, 15:10Tvisha Subhasish: Extravascular Factor IX Beyond the Circulation
-
Sep 3, 2026, 11:21Thrombotic Microangiopathies: From Clinical Syndrome to Molecularly Targeted Therapy
-
Sep 3, 2026, 10:56Elias Othman: Can an Enzyme Involved in Cell Signaling Become a Target for Antithrombotic Drug Discovery?